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Consistency between three different ways of administering the SF-6Dv2 
 
Abstract 
Objective: The Short Form 6 Dimension (SF-6D) is a multi-attribute utility instrument derived from 
the SF-36v2 quality of life questionnaire and is used to calculate QALYs (Quality Adjusted Life 
Years) on a scale 0 to 1. The SF-6Dv2 is a new version of the SF-6D. The aim of this study was to 
DVVHVV WKHFRQVLVWHQF\RI UHVSRQGHQWV¶DQVZHUV WR WKUHHGLIIHUHQWPHWKRGV WRDGPLQLVWHU WKLVQHZ
version. Methods: SF-6Dv2 utility values were generated from the SF-36v2 using: 1) full 
questionnaire with 36 items (SF-6Dv2SF-36); 2) subset questionnaire with 10 items (SF-6Dv2ind-10); 
3) SF-6Dv2 administered as an independent instrument (rephrased questionnaire with only 6 items 
(SF-6Dv2ind-6)). The order of the three instruments was randomly allocated between respondents. 
Results: A total of 782 respondents from Quebec, Canada, were interviewed, out of which 697 fully 
FRPSOHWHGWKHVXUYH\9HU\IHZGHYLDWLRQVLQUHVSRQGHQWV¶DQVZHUVZHUHREVHUYHGEHWZHHQWKHWKUHH
instruments, with mean weighted kappa of 0.79 (range 0.61-0.91) and mean global consistency index 
of 70% (range 54-83). Maximal difference in utility values generated was found between SF-
6Dv2ind-10 and SF-6Dv2ind-6 (mean difference 0.016, p<0.01) while minimal difference was found 
between SF-6Dv2SF-36 and SF-6Dv2ind-10 (0.002, p=0.38). No ceiling effect was observed. 
Conclusions: The SF-6Dv2 was designed to derive utilities from the SF-36v2 and our results 
indicate that it is still preferable to use the full questionnaire although the difference with other 
variants of the questionnaire is very small. To use the SF-6Dv2 as an independent instrument will 
thus introduce minimal bias in utility values generated. 
 
Key words: SF-6Dv2; consistency; health utility; Quebec. 
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Introduction 
A quality adjusted life year (QALY) value is a measure of health related quality of life (HRQoL) 
that is used to guide decisions pertaining to allocation of health-care resources. A QALY can be 
generated in two different ways. It can be generated directly using elicitation techniques (e.g., 
standard gamble, time trade-off), or indirectly using multi-attribute utility instrument (MAUI) [1-
3]. While direct elicitation techniques allow generating accurate measures of QALY for a specific 
population, this is very time consuming and not always appropriate when conducting a clinical 
study, especially in paediatric populations [4]. In contrast, a MAUI is easy to use as it comes with 
a pre-validated questionnaire that incorporates a multi-attribute classification system. In this 
system, a pre-determined utility weight can be assigned to each health status. These weights are 
typically elicited from a sample of the general population. The three most used MAUI are the 
EuroQol 5 dimensions (EQ-5D), the Short-Form 6 Dimensions (SF-6D), and the Health utility 
index (HUI) [2]. Unlike the two other MAUI, the SF-6D is derived from a HRQoL questionnaire, 
namely the Short-form 36 health survey version 2 (SF-36v2). The SF-36v2 is a 36-item generic 
health status instrument and is one of the most widely used HRQoL. However, the SF-36v2 is not 
adapted to generate utilities to calculate QALYs [5]. In order to convert its responses into QALY, 
Brazier et al. [6,7] developed a MAUI, the SF-6Dv1 (previously named SF-6D), using 11 items in 
the SF-36v2 combined in 6 health dimensions. These six dimensions, with 4 to 6 levels each, 
describe 18,000 different health states. Up to eight valuation surveys were carried out in different 
countries around the world to generate value sets that can be used to convert the SF-6Dv1 
responses into utility values for QALY [8]. The first of these value set was generated in the United 
Kingdom [7]. Recently, an improved version of the SF-6D has been developed using classical 
psychometric, Rasch and Item Response Theory techniques [9]. This new version (SF-6Dv2) 
 3 
 
contains only 10 items from the SF-36v2 and can potentially be used in three different ways. First, 
like the SF-6Dv1, it can be used in combination with the responses to the full SF-36v2 
questionnaire (SF-6Dv2SF-36). Second, it may be used as an independent instrument using only the 
10 items requested from the SF-36v2 (SF-6Dv2ind-10). Third, since the 10 items from the SF-36v2 
have been combined and rephrased to generate a questionnaire with 6 questions, the SF-6Dv2 may 
be used as an independent instrument with only these 6 questions (SF-6Dv2ind-6). Compared with 
the SF-6Dv1, the SF-6Dv2 have the same 6 dimensions, but with 5 to 6 levels each, yielding up to 
18,750 health states. 
 
Conventionally, it has been recommended to use the SF-6D conjointly with the SF-36v2 [7]. This 
was confirmed by a study carried out by Ferreira et al. [10]. In this study, they tested if the SF-
6Dv1 can be used as an independent instrument using only the 6 rephrased items from the SF-36v2 
(SF-6Dv1ind-6) (i.e., the classification system of the SF-6Dv1) or if it must be used along with the 
entire SF-36v2 questionnaire (SF-6Dv1SF-36). To do so, the SF-6Dv1SF-36 and SF-6Dv1ind-6 were 
administered to a sample group of 414 respondents from the general Portuguese population. The 
researchers found that the use of the SF-6Dv1ind-6 systematically generated higher values than that 
of the SF-6Dv1SF-36. They also found a significant ceiling effect in the SF-6Dv1ind-6 but not in the 
SF-6Dv1SF-36. This led Ferreira et al. [10] to conclude that the SF-6Dv1 should not be used as an 
independent instrument. However, in their study, they systematically asked respondents to 
complete the SF-36v2 first and then the SF-6Dv1 as an independent instrument. This may have 
generated a bias towards the non-use of the SF-6Dv1 as an independent instrument since it was 
always administered secondly. Indeed, respondents may have been upset, annoyed or simply tired 
of answering the same questions a second time, which could have biased their answers (i.e., a 
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repetition bias). In addition, the sample used in this study was not representative of the general 
population of Portugal, but comprised mostly of students and university staff, which may 
potentially have influenced the results by overestimating index values in a cohort in better health.  
 
In the present study, we propose to test if the different formats in which the SF-6Dv2 can be used 
provide consistent results and if they can be used interchangeably. However, unlike in the study by 
Ferreira et al. [10], we randomly assigned the order of the instruments to avoid any ordering effect. 
In addition, we tested the SF-6Dv2. Since the SF-6Dv2 can potentially be used in three ways (i.e., 
with the full SF-36v2, with the 10 items alone, or with these items combined in a set of 6 
questions), we performed three comparisons to evaluate each of the scenario: SF-6Dv2SF-36 vs. SF-
6Dv2ind-10, SF-6Dv2SF-36 vs. SF-6Dv2ind-6 and SF-6Dv2ind-10 vs SF-6Dv2ind-6.  
 
Methods 
We conducted an internet survey in the Province of Quebec, Canada, in 2016. Respondents were 
solicited from a panel of 4,800 emails obtained from previous studies conducted by the authors in 
the general population and where respondents had voluntarily provided their emails for future 
research. Respondents were contacted in April and a reminder was sent in May. Respondents 
completed the SF-6Dv2SF-36, SF-6Dv2ind-10 and SF-6Dv2ind-6 in a random order. The survey was 
voluntary and anonymous. In addition to the three SF-6Dv2 questionnaires, sociodemographic data 
were also collected. This study was approved by our ethics committee.  
 
Since a value set is neither available for Quebec nor for the SF-6Dv2 [11], we used the value set 
model 10 developed for the United Kingdom (UK) by Brazier et al. [7] to compare the utility 
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values obtained by the three instruments tested. Model 10 is the one recommended by Pickard et 
al. [12]. Considering that this value set has been elicited from the SF-6Dv1 with 11 items 
associated to 4 to 6 levels for each dimension, we made some changes to fit the set adequately with 
the SF-6Dv2 that has six questions. Specifically, the coefficient associated with level 5 in the 
physical functioning dimension was removed (i.e., this specific level was removed from the SF-
6Dv2 classification system) and a coefficient was added for a fifth level in the role limitations 
dimension (i.e., a fifth level has been added in the SF-6Dv2 to consider a permanent role 
limitation; the coefficient corresponds to the highest value obtained in this dimension, that is -
0.055). In addition, to maintain a good correspondence between the answers provided to the 10 
items from the SF-36v2 and the answers to the rephrased 6 questions of the SF-6Dv2, it was 
necessary to recode some answers. Specifically, the physical functioning dimension was recoded 
so as to make it comply with the new structure of the SF-6Dv2 (i.e., answers from the SF-36v2 that 
do not have a correspondence in the SF-6Dv2 classification system take a value of 2) and the role 
limitation and mental health dimensions considered the worst answers to the two items in the SF-
36v2 they are related to. The structure of each instrument derived from the SF-36v2 is provided in 
Table 1. The classification of the SF-6Dv2 is also provided in Table A1 in appendix. 
 
Table 1. Characteristics of the SF-6D instrument 
 
Dimension 
Items extracted from the SF-36 Recoding SF-6Dv2ind-6 
from the SF-36 SF-6Dv1SF-36 SF-6Dv2SF-36 
Physical functioning 
Role limitations 
Social functioning 
Pain 
Mental health 
Vitality 
3a, 3b and 3j 
4c and 5b 
10 
7 and 8 
9b and 9f 
9e 
3a, 3b and 3j 
4b and 5b 
10 
7 
9b and 9f 
9g 
2 if no correspondence 
Worst answer 
NA 
NA 
Worst answer 
NA 
# of items 11 10 6 
Notes: NA is for not applicable 
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Statistical analysis 
Descriptive statistics for sociodemographic variables were calculated. An analysis of the degree of 
agreement between instruments was performed in two steps. In the first step, we analysed the 
distribution of answers for each instrument and calculated the global consistency index (GCI), the 
LGHQWLFDOO\FODVVLILHGLQGH[,&,6SHDUPDQ¶VFRUUHODWLRQFRHIILFLHQWDQGTXDGUDWLFZHLJKWHG
Kappa. The GCI calculates the percentage of individuals classified in the same level of each 
dimension in the two instruments compared: ܩܥܫ= ݆=1݈݆݆݊ܩܥܫ ൌ   ? ௡ೕೕ೗ೕసభ௡ ൈ  ? ? ?          
 (1) 
where n is the total number of subject and njj is the number of individuals with response in the 
VDPHOHYHOMM «ORIDSDUWLFXODUGLPHQVLRQ 
The ICI calculates the percentage of individuals correctly classified in a given level of each 
dimension in the comparison instrument (i.e. the addition of the main diagonal divided by the total 
of subjects):  ܫܥܫ ൌ  ௡೔ೕ௡ೕȈ ൈ  ? ? ?           
 (2) 
where  ௝݊Ȉ ൌ   ? ௝݊௞௟௞ୀଵ  is the total number of responses in level j of a particular dimension in the 
comparison instrument. 
In the second step, utility values were calculated using the value set model 10 of Brazier et al. [7] 
for each individual and each instrument and comparisons were conducted. These comparisons 
were performed for the following measurements: mean, median, range, Kurtosis, Skewness, ceiling 
DQGIORRUHIIHFW3HDUVRQ¶VFRUUHODWLRQFRHIILFLHQWLQWUD-class correlation coefficient (ICC), R 
squared and graphical plot distribution. When appropriate, differences were assessed with paired-
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samples t-test or F test. P-values < 0.05 were considered significant. All analyses were conducted 
with Stata SE (StataCorp LP, Texas, USA). 
 
Results 
 
There was 782 subjects who started the questionnaire and 697 surveys were completed in full. The 
sample was well-balanced as regards to sex, age, marital status, labor market and area of living 
(Table 2). However, the sample included people who are more educated and affluent than the 
general population. 
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Table 2. Sociodemographic variables in our sample as compared to the province of Quebec 
 N sample % sample N Quebec % Quebec 
Sex 
Female 
Male 
 
401 
296 
 
57.5% 
42.5% 
 
3,434,946 
3,351,217 
 
50.6% 
49.4% 
Age group 
ч ? ?ǇĞĂƌƐ 
21-40 years 
41-60 years 
> 60 years 
 
4 
147 
317 
229 
 
0.6% 
21.1% 
45.5% 
32.9% 
 
280,076 
2,228,387 
2,334,060 
1,943,640 
 
4.1% 
32.8% 
34.4% 
28.6% 
Marital status 
Single 
Married/living together 
Divorced/separated 
Widowed 
 
155 
435 
85 
22 
 
22.2% 
62.4% 
12.2% 
3.2% 
 
1,801,686 
3,918,129 
617,130 
450,975 
 
26.5% 
57.7% 
9.1% 
6.6% 
Educational level 
Low 
Middle 
High 
 
134 
254 
309 
 
19.2% 
36.4% 
44.3% 
 
2,828,135 
1,981,400 
1,002,285 
 
48.5% 
34.0% 
17.2% 
Labor market 
Employed 
Student 
Retired 
Unemployed 
 
367 
21 
232 
77 
 
52.7% 
3.0% 
33.3% 
11.0% 
 
4,097,000 
- 
- 
337,200 
 
59.9% 
- 
- 
4.9% 
Area of living 
Urban area 
Rural area 
 
528 
169 
 
75.8% 
24.2% 
 
6,368,270 
1,534,731 
 
81.0% 
19.0% 
Income (K$) 
< 25 
25-50 
50-70 
70-100 
ш ? ? ?
 
103 
152 
135 
161 
146 
 
14.8% 
21.8% 
19.4% 
23.1% 
20.9% 
 
2,787,149 
1,899,596 
823,432 
540,712 
360,481 
 
43.5% 
29.6% 
12.8% 
8.4% 
5.6% 
HRQoL problem 
Yes 
No 
 
303 
394 
 
43.5% 
56.5% 
 
- 
- 
 
- 
- 
Notes: Data for Quebec are the latest available (Institut de la statistique du Québec, Statistique Canada, Revenu Québec). Sex, age 
group, and marital status data for Quebec pertain to people aged 18 or above, whereas other sociodemographic data are for 
people aged 15 or above. 
 
The distribution of the order of administration of the SF-6Dv2 in our survey is presented in Table 
A2 in appendix. Since the distribution of the survey was at random, we have about the same 
number of respondents in each sequence (i.e., 1/6). In Table A3 in appendix, individual responses 
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have been presented across the 6 dimensions and various levels of the three instruments compared. 
We found that most of the responses were located close to the diagonal, indicating that responses 
to each instrument were quite similar. Table 3 presents the deviations in responses between the 3 
instruments. A deviation of 0 indicates that responses are the same and a deviation of 1 indicates 
that they only differ by one level. On average, there was no deviation in 70% of cases (range 54-
83%), and more than 90% of responses differed by only one level or less. 
 
Table 3. Deviation between responses in SF-6Dv2SF-36, SF-6Dv2ind-10 and SF-6Dv2ind-6 
  0 1 2 >2 ׫ 
 SF-6Dv2SF-36 and SF-6Dv2ind-10           
Physical functioning 562 (80.6%) 116 (16.6%) 15 (2.2%) 4 (0.6%) 697 
Role limitations 420 (60.3%) 242 (34.7%) 31 (4.4%) 4 (0.6%) 697 
Social functioning 527 (75.6%) 154 (22.1%) 13 (1.9%) 3 (0.4%) 697 
Pain 572 (82.1%) 114 (16.4%) 8 (1.1%) 3 (0.4%) 697 
Mental health 465 (66.7%) 210 (30.1%) 19 (2.7%) 3 (0.4%) 697 
Vitality 478 (68.6%) 197 (28.3%) 18 (2.6%) 4 (0.6%) 697 
SF-6Dv2SF-36 and SF-6Dv2ind-6           
Physical functioning 498 (71.4%) 171 (24.5%) 20 (2.9%) 8 (1.1%) 697 
Role limitations 407 (58.4%) 238 (34.1%) 47 (6.7%) 5 (0.7%) 697 
Social functioning 519 (74.5%) 158 (22.7%) 18 (2.6%) 2 (0.3%) 697 
Pain 579 (83.1%) 106 (15.2%) 6 (0.9%) 6 (0.9%) 697 
Mental health 377 (54.1%) 260 (37.3%) 51 (7.3%) 9 (1.3%) 697 
Vitality 456 (65.4%) 209 (30.0%) 26 (3.7%) 6 (0.9%) 697 
SF-6Dv2ind-10 and SF-6Dv2ind-6           
Physical functioning 522 (74.9%) 157 (22.5%) 9 (1.3%) 9 (1.3%) 697 
Role limitations 427 (61.3%) 221 (31.7%) 45 (6.5%) 4 (0.6%) 697 
Social functioning 513 (73.6%) 167 (24.0%) 14 (2.0%) 3 (0.4%) 697 
Pain 575 (82.5%) 101 (14.5%) 15 (2.2%) 6 (0.9%) 697 
Mental health 398 (57.1%) 260 (37.3%) 36 (5.2%) 3 (0.4%) 697 
Vitality 490 (70.3%) 191 (27.4%) 15 (2.2%) 1 (0.1%) 697 
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Table 4 presents different measures of agreement between the instruments for each dimension. 
With the exception of the mental health dimension, when comparing SF-6Dv2SF-36 and SF-6Dv2ind-
6, 6SHDUPDQ¶VFRUUHODWLRQFRHIILFLHQWVZHUHDOZD\VKLJKHUWKDQDQGWKHPHDQZHLJKWHG.DSSD
was 0.79 (range 0.61-0.91). Analysis of the results of the global consistency index (GCI), which 
computed the percentage of individuals classified in the same level of each dimension in the 
instruments compared, revealed a high level of agreement in responses with a mean of 70%  (range 
54.1-83.1). The best agreement in each level was found in the categories describing the best level 
(i.e., level 1 ± no problem), while the ICI results decreased for the most severe levels (i.e., levels 5 
and 6). Results suggested that even at these levels the degree of agreement was good, with the 
lowest degree found for the mental health dimension and the highest for the pain dimension. 
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Table 4. Rank correlations, Kappa, GCI and ICI between SF-6Dv2SF-36, SF-6Dv2ind-10 and SF-6Dv2ind-6 
Dimensions 
^ƉĞĂƌŵĂŶ ?Ɛ
correlation 
Weighted 
Kappa GCI ICI (n) 
       1 2 3 4 5 6 
SF-6Dv2SF-36 and SF-6Dv2ind-10 
Physical functioning 0.858* 0.823 80.63 
92.6 
(215) 
83.3 
(287) 
67.1 
(143) 
56.4 
(39) 
46.2 
(13) - 
Role limitations 0.754* 0.762 60.26 
63.3 
(215) 
60.2 
(161) 
61.5 
(218) 
52.6 
(76) 
40.7 
(27) - 
Social functioning 0.762* 0.839 75.61 
85.9 
(327) 
65.5 
(177) 
68.1 
(138) 
66.7 
(39) 
62.5 
(16) - 
Pain 0.915* 0.911 82.07 
85.7 
(105) 
80.6 
(201) 
76.5 
(149) 
87.1 
(155) 
85.3 
(68) 
68.4 
(19) 
Mental health 0.762* 0.756 66.71 
76.7 
(116) 
67.5 
(234) 
66.5 
(248) 
58.5 
(82) 
29.4 
(17) - 
Vitality 0.821* 0.799 68.58 
75.3 
(154) 
57.3 
(211) 
74.9 
(231) 
67.1 
(76) 
68.0 
(25) - 
SF-6Dv2SF-36 and SF-6Dv2ind-6 
Physical functioning 0.761* 0.728 71.45 
85.6 
(215) 
85.0 
(287) 
30.0 
(143) 
59.0 
(39) 
30.8 
(13) - 
Role limitations 0.706* 0.720 58.39 
72.1 
(215) 
53.4 
(161) 
51.4 
(218) 
56.6 
(76) 
40.7 
(27) - 
Social functioning 0.826* 0.826 74.46 
89.0 
(327) 
58.8 
(177) 
66.7 
(138) 
66.7 
(39) 
37.5 
(16) - 
Pain 0.910* 0.904 83.07 
89.5 
(105) 
81.1 
(201) 
80.5 
(149) 
82.6 
(155) 
88.2 
(68) 
73.7 
(19) 
Mental health 0.664* 0.607 54.09 
86.2 
(116) 
53.0 
(234) 
48.8 
(248) 
36.6 
(82) 
11.8 
(17) - 
Vitality 0.749* 0.752 65.42 
66.9 
(154) 
56.4 
(211) 
73.2 
(231) 
69.7 
(76) 
48.0 
(25) - 
SF-6Dv2ind-10 and SF-6Dv2ind-6 
Physical functioning 0.775* 0.755 74.89 
82.8 
(233) 
88.8 
(285) 
36.0 
(125) 
69.2 
(39) 
26.7 
(15) - 
Role limitations 0.734* 0.732 61.26 
81.4 
(172) 
55.0 
(211) 
55.5 
(209) 
55.6 
(81) 
41.7 
(24) - 
Social functioning 0.818* 0.821 73.60 
89.1 
(321) 
55.9 
(186) 
65.4 
(136) 
69.0 
(42) 
41.7 
(12) - 
Pain 0.894* 0.887 82.50 
91.7 
(96) 
80.8 
(193) 
80.3 
(157) 
80.0 
(165) 
86.9 
(69) 
76.5 
(17) 
Mental health 0.747* 0.696 57.10 
92.0 
(125) 
53.2 
(233) 
48.8 
(242) 
46.4 
(84) 
15.4 
(13) - 
Vitality 0.818* 0.830 70.30 
73.2 
(142) 
63.8 
(196) 
76.1 
(251) 
76.7 
(73) 
56.0 
(25) - 
* P < 0.01  
 
       
 
 
In Table 5 we found that the indexes (i.e., the utility value for each instrument) provided very 
similar values. There was no significant difference between SF-6Dv2SF-36 and SF-6Dv2ind-10 (mean 
difference ± SD: -0.002 ± 0.070, p=0.38), but significant difference were observed for SF-6Dv2SF-
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36 and SF-6Dv2ind-6 (0.013 ± 0.075, p<0.01) and between SF-6Dv2ind-10 and SF-6Dv2ind-6 (0.016 ± 
0.077, p<0.01). Similar results can be observed when differences are presented by 
sociodemographic characteristics (see Table A4 in appendix). Table 5 also indicates negligible and 
very similar flRRUQHDUDQGFHLOLQJHIIHFWVDURXQGLQHDFKLQGH[)LQDOO\3HDUVRQ¶VDQG
intra-class correlation coefficients showed good to very good correlations (range 0.73-0.85). These 
results were also confirmed by the graphical plots of the three indexes provided in appendix where 
observations are well distributed along the diagonal.  
Table 5. Descriptive statistics of the three indexes using the value set developed in the United Kingdom  
  SF-6Dv2SF-36 SF-6Dv2ind-10 SF-6Dv2ind-6 
Observed range (theoretical: 0.29 - 1.00) 0.29 - 1.00 0.31 - 1.00 0.31 - 1.00 
Mean (SD) 0.731 (0.128) 0.729 (0.130) 0.745 (0.130) 
Median (IQR) 0.732 (0.64 - 0.82) 0.724 (0.64 - 0.82) 0.737 (0.66 - 0.84) 
Kurtosis 0.0239 0.0851 0.0016 
Skewness  0.3728 0.632 0.183 
Ceiling effect (%) 2.01 1.87 2.58 
Floor effect (%) 0.14 0.00 0.00 
Mean difference with SF-6Dv2SF-36 - -0.002 0.013* 
Mean difference with SF-6Dv2ind-10 0.002 - 0.016* 
Median difference with SF-6Dv2SF-36 - -0.008 0.005 
Median difference with SF-6Dv2ind-10 0.008 - 0.013* 
WĞĂƌƐŽŶ ?ƐĐŽƌƌĞůĂƚŝŽŶǁŝƚŚ^&-6Dv2SF-36 - 0.8515* 0.8299* 
WĞĂƌƐŽŶ ?ƐĐŽƌƌĞůĂƚŝŽŶǁŝƚŚ^&-6Dv2ind-10 0.8515* - 0.8232* 
Intraclass correlation coefficient SF-6Dv2SF-36 -  ? ? ? ? ? ?ɴ 0.776* 
Intraclass correlation coefficient SF-6Dv2ind-10  ? ? ? ? ? ?ɴ - 0.827* 
 ?Wф ? ? ? ? ?ɴ/ǁĂƐĐĂůĐƵůĂƚĞĚĨŽƌƚŚĞƚŚƌĞĞŝŶĚĞǆĞƐƚŽŐĞ ŚĞƌ ? 
 
 
It may be noted that, in very uncommon cases, the intra-class correlation coefficient can become 
negative when the within-groups variance exceeds the between-groups variance. In such cases, the 
,&&LVQRWDSSURSULDWHDQGLWLVEHWWHUWRFRQVLGHUWKH3HDUVRQ¶VFRUUHODWLRQFRHIILFLHQW+RZHYHUWR
overcome this problem it is also possible to consider the ICC for the three groups as a proxy. 
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Two additional analyses were performed to evaluate if the order of administration had an impact 
on results: 1) SF-6Dv2SF-36 systematically administered first and SF-6Dv2ind-10 second (n=112); 
and 2) SF-6Dv2SF-36 systematically administered first and SF-6Dv2ind-6 second (n=114). In these 
WZRVXEJURXSVWKHGHJUHHRIDJUHHPHQWUHPDLQHGYHU\JRRGIRUZHLJKWHG.DSSD6SHDUPDQ¶V
correlation coefficients and GCI. However, the ICI performed poorly than in the whole sample, 
particularly in the second subgroup (see Table A5 in appendix). As regards to the utility values 
generated in these two sub-groups, higher values were generated with SF-6Dv2ind-10 and 
particularly with SF-6Dv2ind-6 (see Table A6 in appendix).  
 
Discussion 
 
In this study, we tested if the different formats in which the SF-6Dv2 can be used provide 
consistent results and if they can be used interchangeably. Exploring the consistency of the SF-
6Dv2, we found very similar results for the three instruments compared, with high degrees of 
agreement, high levels of correlation, and low mean difference. In addition, we found very little 
ceiling effect among the three instruments.  
 
The same methodology as Ferreira et al. [10] was used with the differences that: 1) the instruments 
were administered in a random order; 2) we used the new version of the SF-6D (i.e., SF-6Dv2); 3) 
we also tested if the 10 items from the SF-36v2 can be used alone to calculate a utility value or if it 
is necessary to complete the full questionnaire with 36 items (i.e., not done in the study by Ferreira 
et al. [10]); and 4) an additional agreement measure was used with the quadratic weighted Kappa.  
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Our results were considerably better than those found in the study by Ferreira et al. [10]. With the 
H[FHSWLRQRIWKHPHQWDOKHDOWKGLPHQVLRQ6SHDUPDQ¶VFRUUHODWLRQ coefficients were always higher 
than 0.7, which was never the case in Ferreira et al. [10]. In addition, the GCI percentages are very 
high as compared to those found in Ferreira et al. [10] with a mean difference of 23 percentage 
points, which is more than double for the dimensions of mental health and vitality. This evidence 
of strong agreement between responses was also supported by the results of the ICI, which defines 
the level of stability in responses and is calculated as the percentages of individuals correctly 
classified in a particular level of each dimension. An explanation for this difference can be found 
in the fact that the three instruments were administered in a random order in our study, while the 
SF-6Dv1SF-36 was systematically administered first in the study by Ferreira et al. [10]. This could 
have introduced a systematic bias towards the use of the SF-6Dv1 with the full SF-36v2 
questionnaire.  
 
When exploring the impact of order of administration, the resuls of comparisons in SF-6Dv2SF-36 
systematically administered first and SF-6Dv2ind-6 second matched the most with the poor results 
reported by Ferreira et al. [10]. However, the degree of agreement still remained very good for 
6SHDUPDQ¶VFRUUHODWLRQFRHIILFLHQWVZHLJKWHG.DSSDDQG*&,2QO\WKH,&,SHUIRUPHGPXFKPRUH
poorly than in the whole sample and higher values were generated for utility values. Although 
these differences in utility values were about twice more important than those found in complete 
data, these differences were well below the results of the study by Ferreira et al. [10]. In light of 
these elements, it seems that the order of administration of the instrument could only partially 
explain the results reported by Ferreira et al. [10]. Consequently, there may be other reasons. For 
example, our sample was much more representative of the general population and the number of 
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observations was higher, which could have improved our results. Specifically, Ferreira et al. [10] 
found significant differences between the utility values across sociodemographic groups, which 
was not the case in our study. Also, one should consider that we used a different population than 
Ferreira in terms of region and culture, which may have impacted our results in an unpredictable 
way. However, considering that our sample population was older and more representative of the 
general population than the sample collected by Ferreira et al. [10], our study pertained to a higher 
proportion of severe health states, but also to a better distribution of ratings. This may explain why 
we found no or little ceiling effect in our sample. These elements and the fact that the degree of 
agreement between the instruments was higher in our study reinforce our confidence in our results. 
Indeed, with a better distribution of ratings, we had a higher probability that a respondent changed 
a rating, especially in the middle of the scale, but this was not the case. Finally, in this study we 
used the SF-6Dv2, an improved version of the SF-6D with better psychometric characteristics [9], 
which may have influenced our results in a positive way. 
 
Considering the SF-6Dv2SF-36 as the reference, the worst corresponding results in our study were 
obtained for the SF-6Dv2ind-6, but they were still very good with very high correlation and 
agreement with the SF-6Dv2SF-36 and a small mean difference in utility values. In addition, the 
highest significant difference was found between the SF-6Dv2ind-10 and SF-6Dv2ind-6 with a mean 
difference of 0.016. Even if statistically significant (p<0.01), this difference is very small and well 
below the mean minimally important difference (MID) of 0.041 reported by Walters and Brazier 
[13] for a change in QALY. As compared to the results of Ferreira et al. [10], our results indicated 
a difference 4 to 60 times less important. When comparing the index SF-6Dv2SF-36 with SF-
6Dv2ind-6, as Ferreira et al. [10] did, the difference in our sample was only of 0.013, which is 9 
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times less important with the same value set used to convert into QALY (i.e., UK value set). We 
believe that the minor differences between instruments found in our study were mainly due to 
random errors with respondents simply making mistakes when answering each question. These 
results thus indicate that the SF-6Dv2 may potentially be used as an independent instrument with 
minimal bias, both for SF-6Dv2ind-10 and SF-6Dv2ind-6. Indeed, our results indicate that to complete 
the classification system of the SF-6Dv2 alone will lead to small differences in responses and 
utility values. 
 
In addition, since the utilities from the UK value set have been generated using direct elicitation 
techniques with the phrasing of the 6 dimensions of the SF-6Dv2 and not with the phrasing of the 
items in the SF-36v2, it may be deemed paradoxical that the SF-6D should be administered 
through the SF-36v2. Historically, this was justified by the fact that the SF-6D was designed to 
derive utilities from the SF-36v2. However, if we can use the SF-6Dv2 as an independent 
instrument without changing the results in utility values, this can change a lot in how surveys are 
conducted; particularly, it will considerably reduce the length of the questionnaire (i.e., 6 questions 
instead of 36) and fatigue to patients. However, we should remain cautious since the mean 
differences values obtained in this study can hide small but significant discrepancies between 
UHVSRQGHQWV¶DQVZHUVDVVKRZQLQ7DEOH 
 
A limit in our study is that we do not know if we would get the same results in another context 
(i.e., outside Quebec), since how to complete the SF-6Dv2 instruments could be different among 
different people because of the way they interpret the questions and possible answers. One study is 
not sufficient and others should be conducted to confirm these results. Moreover, it will be 
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necessary to redo this analysis when a value set is available with the SF-6Dv2, and particularly for 
Quebec. Considering that health preferences can be different between countries [8], it is necessary 
to have a value set for Quebec to confirm our results. Furthermore, some authors indicate that it 
would also be necessary to assess the preferences of sick populations [14-15], but actually it will in 
contradiction with the theoretical model of QALY which aims to help a decision-making based on 
the point of view of the general population (i.e. the tax-payer) [3]. Another limit of our study is 
that we did not compare the SF-6Dv1 with the SF-6Dv2, which may have contributed to assess the 
validity of the new SF-6D version. 
 
To conclude, even if the use of the full SF-36v2 questionnaire is still recommended to generate 
utility values from the SF-6D, this study provides evidence that the SF-6Dv2 may be used as an 
independent instrument with minimal bias, either in combination with the 10 items from the SF-
36v2, or with the classification system used in the SF-6Dv2 (i.e., 6 questions). 
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